Less invasive surgery for early-stage cervical cancer
Part of Cancer, Pain, Women’s health & pregnancy clinical trials.
This study tests a newer, less invasive way to remove the uterus and cervix in early-stage cervical cancer (tumor size 2–4 cm). The goal is to see if using a special stapling device makes the surgery safer with fewer side effects, while still effectively treating the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stage IB2 or IIA1 cervical cancer, with tumor size between 2 and 4 cm.
- Your cancer type is squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma.
- You are scheduled for a radical hysterectomy (removal of the uterus and surrounding tissue).
- Your blood counts and liver/kidney function are within acceptable levels.
- You are in generally good health (able to do light activities).
- You haven't had radiation or chemotherapy for this cancer before surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a modified, less-invasive tumor removal approach with standard surgery for people with early stage (IB2) cervical cancer. It aims to see if this technique reduces the risk of cancer coming back while helping you heal faster.
This trial tests how safe a specific minimally invasive surgery tool (an endoscopic stapler) is for people with early-stage cervical cancer. If you qualify, you would get surgery to remove the cervix area using a minimally invasive approach and the study will track safety outcomes.
This study compares two ways to check lymph nodes during surgery for early-stage endometrial (uterine) cancer: sentinel node biopsy versus removing more lymph nodes. It may help find whether the less extensive approach can stage the cancer accurately with fewer side effects.
This trial compares two ways of performing a radical hysterectomy (removal of the uterus and surrounding tissue) for early-stage cervical cancer: minimally invasive surgery versus traditional open surgery. The goal is to find out which approach is safer and more effective for treating the cancer.
This study tests whether a less invasive type of hysterectomy (keyhole surgery) works well for women with very early-stage cervical cancer. It aims to find a safer, faster recovery option for low-risk tumors.
This study looks at two ways to remove the uterus and cervix for early-stage cervical cancer: minimally invasive surgery (like laparoscopic or robotic) versus open surgery (traditional large incision). It checks whether the less invasive approach works just as well in terms of survival and keeping the cancer from coming back.
Hear when a new Cervical Cancer Stage IB2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.